Found: 69
Select item for more details and to access through your institution.
Alternating rabacfosadine and doxorubicin for treatment of naïve canine lymphoma.
- Published in:
- Veterinary & Comparative Oncology, 2024, v. 22, n. 2, p. 278, doi. 10.1111/vco.12975
- By:
- Publication type:
- Article
VDX-111 targets proliferative pathways in canine cancer cell lines.
- Published in:
- PLoS ONE, 2024, v. 19, n. 5, p. 1, doi. 10.1371/journal.pone.0303470
- By:
- Publication type:
- Article
Review: The PI3K-AKT-mTOR signal transduction pathway in canine cancer.
- Published in:
- Veterinary Pathology, 2024, v. 61, n. 3, p. 339, doi. 10.1177/03009858231207021
- By:
- Publication type:
- Article
Editorial.
- Published in:
- 2024
- By:
- Publication type:
- Editorial
Immunohistochemical evidence of NF-kB activation in canine lymphomas, histiocytic sarcomas, hemangiosarcomas, and mast cell tumors.
- Published in:
- Veterinary Pathology, 2024, v. 61, n. 1, p. 20, doi. 10.1177/03009858231180484
- By:
- Publication type:
- Article
Individualized chemotherapy drug dose escalation in dogs with multicentric lymphoma.
- Published in:
- Journal of Veterinary Internal Medicine, 2023, v. 37, n. 6, p. 2402, doi. 10.1111/jvim.16875
- By:
- Publication type:
- Article
Tumor-associated macrophages: Prognostic and therapeutic targets for cancer in humans and dogs.
- Published in:
- Frontiers in Immunology, 2023, v. 14, p. 01, doi. 10.3389/fimmu.2023.1176807
- By:
- Publication type:
- Article
Configuration of pathologic fractures in dogs with osteosarcoma following stereotactic body radiation therapy: A retrospective analysis.
- Published in:
- Veterinary & Comparative Oncology, 2023, v. 21, n. 1, p. 131, doi. 10.1111/vco.12877
- By:
- Publication type:
- Article
Review: NF-kB activation in canine cancer.
- Published in:
- Veterinary Pathology, 2022, v. 59, n. 5, p. 724, doi. 10.1177/03009858221092017
- By:
- Publication type:
- Article
Increased incidence of gastrointestinal toxicity in canine cancer patients treated with concurrent abdominal radiation therapy and toceranib phosphate.
- Published in:
- Veterinary & Comparative Oncology, 2022, v. 20, n. 1, p. 142, doi. 10.1111/vco.12756
- By:
- Publication type:
- Article
Multicenter, randomized, double‐blinded, placebo‐controlled study of rabacfosadine in dogs with lymphoma.
- Published in:
- Journal of Veterinary Internal Medicine, 2022, v. 36, n. 1, p. 215, doi. 10.1111/jvim.16341
- By:
- Publication type:
- Article
Biological behaviour of primary osteosarcoma of the digits, metacarpal and metatarsal bones in dogs.
- Published in:
- Veterinary & Comparative Oncology, 2021, v. 19, n. 4, p. 735, doi. 10.1111/vco.12652
- By:
- Publication type:
- Article
Immune pathways and TP53 missense mutations are associated with longer survival in canine osteosarcoma.
- Published in:
- Communications Biology, 2021, v. 4, n. 1, p. 1, doi. 10.1038/s42003-021-02683-0
- By:
- Publication type:
- Article
Prospective clinical trial testing COXEN-based gene expression models of chemosensitivity in dogs with spontaneous osteosarcoma.
- Published in:
- 2021
- By:
- Publication type:
- journal article
There and back again: Translating adoptive cell therapy to canine cancer and improving human treatment.
- Published in:
- Veterinary & Comparative Oncology, 2021, v. 19, n. 3, p. 420, doi. 10.1111/vco.12744
- By:
- Publication type:
- Article
Adjuvant carboplatin for treatment of splenic hemangiosarcoma in dogs: Retrospective evaluation of 18 cases (2011‐2016) and comparison with doxorubicin‐based chemotherapy.
- Published in:
- Journal of Veterinary Internal Medicine, 2021, v. 35, n. 4, p. 1929, doi. 10.1111/jvim.16212
- By:
- Publication type:
- Article
Canine lymphoma in 1914.
- Published in:
- Veterinary & Comparative Oncology, 2021, v. 19, n. 1, p. 1, doi. 10.1111/vco.12670
- By:
- Publication type:
- Article
Predicting likelihood of in vivo chemotherapy response in canine lymphoma using ex vivo drug sensitivity and immunophenotyping data in a machine learning model.
- Published in:
- Veterinary & Comparative Oncology, 2021, v. 19, n. 1, p. 160, doi. 10.1111/vco.12656
- By:
- Publication type:
- Article
Prospective evaluation of flow cytometric characteristics, histopathologic diagnosis and clinical outcome in dogs with naïve B‐cell lymphoma treated with a 19‐week CHOP protocol.
- Published in:
- Veterinary & Comparative Oncology, 2020, v. 18, n. 3, p. 342, doi. 10.1111/vco.12553
- By:
- Publication type:
- Article
Drug dose and drug choice: Optimizing medical therapy for veterinary cancer.
- Published in:
- Veterinary & Comparative Oncology, 2020, v. 18, n. 2, p. 143, doi. 10.1111/vco.12537
- By:
- Publication type:
- Article
Phosphorylated KIT as a predictor of outcome in canine mast cell tumours treated with toceranib phosphate or vinblastine.
- Published in:
- Veterinary & Comparative Oncology, 2020, v. 18, n. 2, p. 169, doi. 10.1111/vco.12525
- By:
- Publication type:
- Article
Auranofin improves overall survival when combined with standard of care in a pilot study involving dogs with osteosarcoma.
- Published in:
- Veterinary & Comparative Oncology, 2020, v. 18, n. 2, p. 206, doi. 10.1111/vco.12533
- By:
- Publication type:
- Article
Phase-I trial of survivin inhibition with EZN-3042 in dogs with spontaneous lymphoma.
- Published in:
- BMC Veterinary Research, 2020, v. 16, n. 1, p. 1, doi. 10.1186/s12917-020-02317-3
- By:
- Publication type:
- Article
Concurrent use of rabacfosadine and L‐asparaginase for relapsed or refractory multicentric lymphoma in dogs.
- Published in:
- Journal of Veterinary Internal Medicine, 2020, v. 34, n. 2, p. 882, doi. 10.1111/jvim.15723
- By:
- Publication type:
- Article
Prognostic and predictive significance of KIT protein expression and c‐kit gene mutation in canine cutaneous mast cell tumours: A consensus of the Oncology‐Pathology Working Group.
- Published in:
- Veterinary & Comparative Oncology, 2019, v. 17, n. 4, p. 451, doi. 10.1111/vco.12518
- By:
- Publication type:
- Article
Bacterial Killing Activity of Polymorphonuclear Myeloid-Derived Suppressor Cells Isolated From Tumor-Bearing Dogs.
- Published in:
- Frontiers in Immunology, 2019, p. 1, doi. 10.3389/fimmu.2019.02371
- By:
- Publication type:
- Article
Ivermectin inhibits canine mammary tumor growth by regulating cell cycle progression and WNT signaling.
- Published in:
- BMC Veterinary Research, 2019, v. 15, n. 1, p. N.PAG, doi. 10.1186/s12917-019-2026-2
- By:
- Publication type:
- Article
A temporary indwelling intravascular aphaeretic system for in vivo enrichment of circulating tumor cells.
- Published in:
- Nature Communications, 2019, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41467-019-09439-9
- By:
- Publication type:
- Article
Prognostic value of fluorine<sup>18</sup> flourodeoxyglucose positron emission tomography/computed tomography in dogs with appendicular osteosarcoma.
- Published in:
- Journal of Veterinary Internal Medicine, 2019, v. 33, n. 2, p. 820, doi. 10.1111/jvim.15453
- By:
- Publication type:
- Article
Prognostic significance of circulating microRNA-214 and -126 in dogs with appendicular osteosarcoma receiving amputation and chemotherapy.
- Published in:
- BMC Veterinary Research, 2019, v. 15, n. 1, p. 1, doi. 10.1186/s12917-019-1776-1
- By:
- Publication type:
- Article
Post-surgical outcome and prognostic factors in canine malignant melanomas of the haired skin: 87 cases (2003-2015).
- Published in:
- Canadian Veterinary Journal / Revue Vétérinaire Canadienne, 2018, v. 59, n. 9, p. 981
- By:
- Publication type:
- Article
Postsurgical Outcome in Cats with Exocrine Pancreatic Carcinoma: Nine Cases (2007–2016).
- Published in:
- Journal of the American Animal Hospital Association, 2018, v. 54, n. 5, p. 291, doi. 10.5326/JAAHA-MS-6780
- By:
- Publication type:
- Article
In vitro effects of PI3K/mTOR inhibition in canine hemangiosarcoma.
- Published in:
- PLoS ONE, 2018, v. 13, n. 7, p. 1, doi. 10.1371/journal.pone.0200634
- By:
- Publication type:
- Article
In vitro antineoplastic effects of auranofin in canine lymphoma cells.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Comparative oncology approach to drug repurposing in osteosarcoma.
- Published in:
- PLoS ONE, 2018, v. 13, n. 3, p. 1, doi. 10.1371/journal.pone.0194224
- By:
- Publication type:
- Article
Proteus mirabilis inhibits cancer growth and pulmonary metastasis in a mouse breast cancer model.
- Published in:
- PLoS ONE, 2017, v. 12, n. 12, p. 1, doi. 10.1371/journal.pone.0188960
- By:
- Publication type:
- Article
Relative biological effectiveness in canine osteosarcoma cells irradiated with accelerated charged particles.
- Published in:
- Oncology Letters, 2016, v. 12, n. 2, p. 1597, doi. 10.3892/ol.2016.4808
- By:
- Publication type:
- Article
Intrinsic Radiosensitivity and Cellular Characterization of 27 Canine Cancer Cell Lines.
- Published in:
- PLoS ONE, 2016, v. 11, n. 6, p. 1, doi. 10.1371/journal.pone.0156689
- By:
- Publication type:
- Article
Perspectives from man’s best friend: National Academy of Medicine’s Workshop on Comparative Oncology.
- Published in:
- 2016
- By:
- Publication type:
- Proceeding
Maintenance therapy with toceranib following doxorubicin-based chemotherapy for canine splenic hemangiosarcoma.
- Published in:
- BMC Veterinary Research, 2015, v. 11, n. 1, p. 1, doi. 10.1186/s12917-015-0446-1
- By:
- Publication type:
- Article
Maintenance therapy with toceranib following doxorubicin-based chemotherapy for canine splenic hemangiosarcoma.
- Published in:
- BMC Veterinary Research, 2015, v. 11, n. 1, p. 131, doi. 10.1186/s12917-015-0446-1
- By:
- Publication type:
- Article
The effect of Zhangfei/CREBZF on cell growth, differentiation, apoptosis, migration, and the unfolded protein response in several canine osteosarcoma cell lines.
- Published in:
- BMC Veterinary Research, 2015, v. 11, n. 1, p. 1, doi. 10.1186/s12917-015-0331-y
- By:
- Publication type:
- Article
The immunosignature of canine lymphoma: characterization and diagnostic application.
- Published in:
- BMC Cancer, 2014, v. 14, p. 1, doi. 10.1186/1471-2407-14-657
- By:
- Publication type:
- Article
Malignant mesenchymoma with widespread metastasis including bone marrow involvement in a dog.
- Published in:
- Veterinary Clinical Pathology, 2014, v. 43, n. 3, p. 447, doi. 10.1111/vcp.12180
- By:
- Publication type:
- Article
Development of an in vitro model of acquired resistance to toceranib phosphate (Palladia®) in canine mast cell tumor.
- Published in:
- BMC Veterinary Research, 2014, v. 10, n. 1, p. 1, doi. 10.1186/1746-6148-10-105
- By:
- Publication type:
- Article
GS-9219/VDC-1101 - a prodrug of the acyclic nucleotide PMEG has antitumor activity in spontaneous canine multiple myeloma.
- Published in:
- BMC Veterinary Research, 2014, v. 10, n. 1, p. 1, doi. 10.1186/1746-6148-10-30
- By:
- Publication type:
- Article
The immunosignature of canine lymphoma: characterization and diagnostic application.
- Published in:
- 2014
- By:
- Publication type:
- journal article
HES1, a target of Notch signaling, is elevated in canine osteosarcoma, but reduced in the most aggressive tumors.
- Published in:
- BMC Veterinary Research, 2013, v. 9, n. 1, p. 1, doi. 10.1186/1746-6148-9-130
- By:
- Publication type:
- Article
DNA Repair Deficiency as a Susceptibility Marker for Spontaneous Lymphoma in Golden Retriever Dogs: A Case-Control Study.
- Published in:
- PLoS ONE, 2013, v. 8, n. 7, p. 1, doi. 10.1371/journal.pone.0069192
- By:
- Publication type:
- Article
Tyrosine kinase inhibitor special issue Tyrosine kinase inhibitor special issue.
- Published in:
- Veterinary & Comparative Oncology, 2012, v. 10, n. 3, p. 161, doi. 10.1111/j.1476-5829.2012.00339.x
- By:
- Publication type:
- Article